Drug Safety Information for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM (Amlodipine besylate; atorvastatin calcium)
Safety-related Labeling Changes for CADUET (AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM) Rx Drug: FDA Link
Adverse Drug Reactions for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM* (Amlodipine besylate; atorvastatin calcium)
These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).
Top 20 Adverse Effects Associated with AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
(reported in FDA Medwatch/FAERS Reports)
|Side Effect||# of FDA Reports|
|13||Blood glucose increased||82|
|14||Pain in extremity||81|
|16||Blood pressure increased||80|
|19||Cardiac failure congestive||69|
* This side effect also appears in "Top 10 Side Effects of AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM " in the drug's Review Summary based on AskaPatient reviews.
Top 10 Reasons for Taking AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
(associated with FDA Medwatch/FAERS Reports)
|Reason||# of FDA Reports|
|2||Blood cholesterol increased||1157|
|3||Product used for unknown indication||684|
|9||Blood pressure abnormal||41|
*Also a top-10 reason in AskaPatient Review Summary.
Types of Adverse Events for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Total Reports Filed with FDA: 10202
Number of FDA Adverse Event Reports by Patient Age for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Total Reports Filed with FDA: 10202*
* Reports for drugs with the same active ingredients have been aggregated in this analysis: Amlodipine besylate; atorvastatin calcium (Caduet)
Charts are based on 10202 reports filed with the FDA between 2004 and June 2015.
Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.
Click to go back to search results and AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM Reviews and Review Summary .
Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.